You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models

 

Online download statistics by month:

Online download statistics by month: January 2020 to August 2024

AbstractFullPdf
Jan 2020326326126
Feb 2020405405147
Mar 202019619653
Apr 2020979757
May 202013913952
Jun 2020909036
Jul 2020808033
Aug 2020939331
Sep 202014014045
Oct 202016316367
Nov 202014614763
Dec 202016016055
Jan 202118918964
Feb 202118118157
Mar 202131631681
Apr 202125925976
May 202118218277
Jun 202117417469
Jul 202112012055
Aug 202111711781
Sep 202114214277
Oct 202113413481
Nov 202116316265
Dec 202112312441
Jan 202212413037
Feb 20229810147
Mar 202215616059
Apr 202211812539
May 202213413844
Jun 202212713842
Jul 2022929632
Aug 202211311835
Sep 2022838570
Oct 202212613048
Nov 2022949749
Dec 2022656618
Jan 2023697020
Feb 20239810125
Mar 2023636719
Apr 2023747531
May 2023555521
Jun 2023616317
Jul 2023535426
Aug 2023686830
Sep 2023546035
Oct 2023686826
Nov 2023838533
Dec 2023727332
Jan 2024373823
Feb 2024596121
Mar 2024798138
Apr 2024656634
May 2024636627
Jun 2024505020
Jul 2024656929
Aug 2024464655
Total674768362671